Thomas Civik Five Prime Therapeutics, Inc. (FPRX) insider trading activity

FPRX Quotes by TradingView

Thomas Civik is President and CEO of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of FPRX, which is worth approximately $0. The most recent transaction as insider was on Apr 16, 2021, when has been sold 68,971 shares (Common Stock) at a price of $38.0 per share, resulting in proceeds of $2,620,898. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas Civik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2021
SELL
Sale (or disposition) back to the issuer
$2,620,898 $38.0 p/Share
68,971 Reduced 100.0%
0 Common Stock
Apr 09 2021
SELL
Payment of exercise price or tax liability
$420,679 $37.94 p/Share
11,088 Reduced 13.85%
68,971 Common Stock

Also insider at

RPTX
Repare Therapeutics Inc. Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
TC

Thomas Civik

President and CEO
St Laurent, A8

Track Institutional and Insider Activities on FPRX

Follow FIVE PRIME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FPRX shares.

Notify only if

Insider Trading

Get notified when an Five Prime Therapeutics, Inc. insider buys or sells FPRX shares.

Notify only if

News

Receive news related to FIVE PRIME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FPRX